Bandelow, Borwin

Epidemiology of anxiety disorders in the 21st century

Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 2,079

Treatment of anxiety disorders

Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Cited by 811

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 676

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 617

Efficacy of treatments for anxiety disorders: a meta-analysis

Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D. (2015) · International Clinical Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 555

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

Bandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H.-J., WFSBP Task Force on Mental Disorders in Primary Care, & WFSBP Task Force on Anxiety Disorders, O. A. P. (2012) · International Journal of Psychiatry in Clinical Practice

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 428

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 347

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

Bandelow, B. (1995) · International Clinical Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

Cited by 314

What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

Bandelow, B., Baldwin, D. S., Dolberg, O. T., Andersen, H. F., & Stein, D. J. (2006) · The Journal of Clinical Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 203

Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 166

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Cited by 158

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

Bandelow, B., Chouinard, G., Bobes, J., Ahokas, A., Eggens, I., Liu, S., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 142

Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis

Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 140

Borderline personality disorder: a dysregulation of the endogenous opioid system?

Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review

Personality Disorders and PsychopathologyPersonality Traits and Psychology

Cited by 135

The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practice

Möller, H.-J., Bandelow, B., Volz, H.-P., Barnikol, U. B., Seifritz, E., & Kasper, S. (2016) · European Archives of Psychiatry and Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 127

Blood Dyscrasias Induced by Psychotropic Drugs

Stübner, S., Grohmann, R., Engel, R. R., Bandelow, B., Ludwig, W.-D., Wagner, G., Müller-Oerlinghausen, B., Möller, H. ‐., Hippius, H., & Rüther, E. (2004) · Pharmacopsychiatry

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 100

The German Guidelines for the treatment of anxiety disorders: first revision

Bandelow, B., Werner, A. M., Kopp, I., Rudolf, S., Wiltink, J., & Beutel, M. E. (2022) · European Archives of Psychiatry and Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 90

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD

Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Hollander, E., Kasper, S., Möller, H.-J., et al. (2023) · The World Journal of Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 84

Enduring effects of psychological treatments for anxiety disorders: Meta-analysis of follow-up studies

Bandelow, B., Sagebiel, A., Belz, M., Görlich, Y., Michaelis, S., & Wedekind, D. (2018) · The British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 70

An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder

Baldwin, D. S., Allgulander, C., Bandelow, B., Ferre, F., & Pallanti, S. (2012) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 69

Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

Hajak, G., Rodenbeck, A., Adler, L., Huether, G., Bandelow, B., Herrendorf, G., Staedt, J., & Rüther, E. (1996) · Pharmacopsychiatry

Sleep and related disordersCircadian rhythm and melatonin

Cited by 62

Treatment-Resistant Panic Disorder

Bandelow, B., & Rüther, E. (2004) · CNS Spectrums

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Cited by 57

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

Bandelow, B., Broocks, A., Pekrun, G., George, A., Meyer, T., Pralle, L., Bartmann, U., Hillmer-Vogel, U., & Rüther, E. (2000) · Pharmacopsychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCardiac Health and Mental Health

Cited by 53

Defining Response and Remission in Anxiety Disorders: Toward an Integrated Approach

Bandelow, B. (2006) · CNS Spectrums

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 52